Skip to main content
Skip to section navigation
Skip to footer
Mineralys Therapeutics, Inc.
About
Team
Investor Relations
Publications
News
Careers
Contact
All SEC Filings
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Presentations
Email Alerts
SEC Filings
All SEC Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Board Diversity Matrix
Filing Type:
View All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
Date
Form
Description
PDF
XBRL
Pages
02/14/24
4
Statement of changes in beneficial ownership of securities
1
02/14/24
4
Statement of changes in beneficial ownership of securities
2
02/14/24
4
Statement of changes in beneficial ownership of securities
2
02/14/24
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
02/13/24
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
Documents
expand_more
EX-99.1
11
02/13/24
SC 13G
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
3
02/13/24
4
Statement of changes in beneficial ownership of securities
1
02/12/24
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
8
02/12/24
SC 13D/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
4
02/08/24
8-K
Current report filing
Documents
expand_more
EX-4.1
EX-10.1
EX-99.1
53
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
…
Page
3
Page
4
Page
5
Page
6
Page
7
Page
8
Page
9
Page
10
Page
11
Page
12
…
…
Page
16
Next Page
arrow_forward
Email Alerts
Contacts
RSS News Feed